Not applicableStudy completedNCT00899366What this trial is testingDNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia ECOG-ACRIN Cancer Research Group 49
Testing effectiveness (Phase 2)Study completedNCT00014469What this trial is testingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02065869What this trial is testingSafety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+10 more Bellicum Pharmaceuticals 187
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Study completedNCT00301938What this trial is testing7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+23 more National Cancer Institute (NCI) 30
Early research (Phase 1)WithdrawnNCT04464889What this trial is testingHA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+5 more Medigene AG
Very early researchLooking for participantsNCT04532281What this trial is testingMurine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft Tissue Zhejiang University 120
Large-scale testing (Phase 3)WithdrawnNCT00943709What this trial is testingIntensive Glycemic Control on Infectious Morbidity In Patients With Acute LeukemiaWho this might be right forHyperglycemiaLeukemia University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT00949117What this trial is testingCyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With CancerWho this might be right forLeukemiaLymphomaMalnutrition+3 more University of South Florida 9
Not applicableLooking for participantsNCT06389305What this trial is testingCIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell DysfunctionWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoid Leukemia Beijing GoBroad Hospital 213
Testing effectiveness (Phase 2)Ended earlyNCT03333486What this trial is testingFludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more Roswell Park Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT00079391What this trial is testingStem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow MalignanciesWho this might be right forHematologic MalignanciesBone Marrow Transplant Rejection National Heart, Lung, and Blood Institute (NHLBI) 50
Early research (Phase 1)Ended earlyNCT00618696What this trial is testingYttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 4
Early research (Phase 1)Not Yet RecruitingNCT07043218What this trial is testingA Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaWho this might be right forB-cell Acute Lymphoblastic Leukemia Shanghai Tongji Hospital, Tongji University School of Medicine 36
Very early researchLooking for participantsNCT07074496What this trial is testingEfficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.Who this might be right forPhiladelphia Chromosome-Positive Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Active Not RecruitingNCT04629729What this trial is testingFT819 in Subjects With B-cell MalignanciesWho this might be right forLymphoma, B-CellChronic Lymphocytic LeukemiaPrecursor B-Cell Acute Lymphoblastic Leukemia Fate Therapeutics 54
Testing effectiveness (Phase 2)UnknownNCT02965092What this trial is testingCD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaB Cell Lymphoma Wuhan Sian Medical Technology Co., Ltd 80
Testing effectiveness (Phase 2)Looking for participantsNCT05281809What this trial is testingLocal Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic LeukemiaWho this might be right forB-Cell LymphomaB Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+6 more John Lister 30
Not applicableStudy completedNCT05440409What this trial is testingCAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALLWho this might be right forLeukemia, Acute LymphoblasticLymphoblastic Leukemia, Acute, Childhood National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00378534What this trial is testingMethods to Enhance the Safety and Effectiveness of Stem Cell TransplantsWho this might be right forChronic Myelogenous LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+2 more National Heart, Lung, and Blood Institute (NHLBI) 116